Antimicrobial Agents and Chemotherapy · 2019 · 63 citations · 34 references
PharmacyInfectious DiseasesPharmacologyDrug DeliveryHiv ControlInflammationAntiretroviral TherapyAntiviral PharmacotherapyAntiviral TherapyHuman Immunodeficiency Virus PharmacotherapyImplantable Drug Delivery SystemsPrimate MedicineFibrous EncapsulationImplant PharmacokineticsImplant-associated InflammationImplantation Site PharmacokineticsLong-acting Injectable ImplantsReservoir Implant SystemsReservoir-based ImplantsTenofovir Therapy
rhesus macaque peripheral blood mononuclear cells at a TAF dose of 10 μg/kg/day. This dose and flux of TAF also resulted in adverse local inflammation and necrosis near the implant in rhesus macaques. The level of inflammation in the primates was markedly lower in the placebo group than in the active-implant group. The histological inflammatory response to the TAF implant at 4 and 12 weeks in primates was graded as a severe reaction. Thus, while we were able to achieve a sustained target dose, we observed an unacceptable inflammatory response locally at the implant tissue interface.
34
Guide for the Care and Use of Laboratory Animals (8th edn)
Udo Albus · Laboratory Animals · 2012 · 1.7K citations · Full text